Salvianolic Acids for Injection Alleviates Cerebral Ischemia/Reperfusion Injury by Switching M1/M2 Phenotypes and Inhibiting NLRP3 Inflammasome/Pyroptosis Axis in Microglia In Vivo and In Vitro.